Prof. Dr. Niklaus Labhardt, MD, DTM&H, MIH

Niklaus Labhardt is a physician trained in Switzerland, Cameroon and Lesotho, specialized in Infectious Diseases and Tropical Medicine with a Master in International Health. He currently holds a position as senior infectious disease doctor at the University Hospital of Basel, Switzerland and leads the research group "HIV and Chronic Disease Care" at the Swiss Tropical and Public Health Institute.

His research group's work embraces clinical, epidemiological, molecular and implementation research focusing on HIV and comorbidities in Lesotho and other settings in Southeastern Africa. He is the sponsor/chief-investigator of several published or ongoing randomized controlled trials addressing questions around community-based HIV testing and care, improvement of the care-cascade, cost-effective differentiated service delivery models or treatment failure in persons living with HIV in resource-limited settings. As president of board of the Swiss not-for-profit organization SolidarMed, he is committed to improved health for persons living in rural areas in Subsaharan Africa (www.solidarmed.ch)

Current positions

-          Research Group Leader International HIV and chronic disease care at Swiss Tropical and Public Health Institute

-          Senior physician in infectious diseases at the University Hospital Basel

-          President of Board SolidarMed, Partnerships for Health

Accademic achievements and diplomas   

2018    SNSF Eccellenza Professorship

2018    Assistant Professor at the University of Basel

2017    Specialist in Tropical and Travel Medicine, Swiss Society of Tropical Medicine

2015    Specialist in General Internal Medicine, Swiss Society of General Internal Medicine

2010    Master of Advanced Studies in International Health (MIH), University of Basel

2009    Diploma in Health Care Management in Tropical Countries (HCMTC), University of Basel

2005    Medical Doctoral Thesis, Medical Faculty of the University of Basel

2004    Physician Diploma, Medical Faculty of the University of Basel

Clinical training

-          Infectious Diseases at University Hospital Basel

-          Tropical Medicine at Swiss Tropical and Public Health Institute, District Hospital Mfou, Cameroon and St Charles Mission Hospital Seboche, Lesotho

-          Internal Medicine at Kantonsspital Basel-Land and Hôpital du Jura

Prices/Awards

2018   First Prize of the SSI/SAFE-ID AWARDS 2018 - “clinical research in infectious diseases”

2019   Pfizer Forschungspreis 2019 in Infektiologie, Rheumatologie und Immunolog

Larger grants as main applicant (>400’000)           

2016   Swiss National Science Foundation (R4D Open Call, 160876; CHF 499’000)                

2018   Swiss National Science Foundation (PCEFP3_181355; CHF 1'559'950)

2019   Fondation Botnar (CHF 700’000)

Wang T, Bisson W.H, Mäser P, Scapozza L, Picard D. Differences in conformational dynamics between Plasmodium falciparum and human Hsp90 orthologues enable the structure-based discovery of pathogen-selective Inhibitors. J Med Chem. 2014;57(6):2524-2535. DOI: 10.1021/jm401801t

Thun G.A. Lung function in the general population: the complex interplay of variants in Serpina1 and other genes with the environment. Basel: Univ. Basel, 2013. PhD Thesis, University of Basel, Faculty of Science DOI: 10.5451/unibas-006222205

Zinsstag J, Bonfoh B, Schelling E. Approche "une santé unique" de la surveillance humaine et animale. In: Gauthier-Clerc M,Thomas F, eds. Écologie de la santé et biodiversité, 294-297. Bruxelles: Groupe De Boeck, 2010

Tasdemir D, Lack G, Brun R, Ruedi P, Scapozza L, Perozzo R. Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids. J Med Chem. 2006;49(11):3345-3353

Degrémont A. Chimiothérapie moderne des helminthiases. Ther Umsch. 1974;31:396-401

Perret B.A. The venom of the east African spider Pterinochilus sp.. Toxicon. 1974;12(3):303-310